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Introduction:  Lymphoepithelial  carcinoma  is  a rare  tumour,  named  after  its  histological  resemblance  to
undifferentiated  nasopharyngeal  carcinoma.  The  pathogenesis  of  lymphoepithelial  carcinoma  remains
unknown.  This  tumour  has  been  described  in  several  organs,  but the  larynx  remains  an  exceptional  site.
Case  report:  The  authors  report  the  case  of a 73-year-old  man  who  consulted  for longstanding  dys-
phonia  and  rapidly  deteriorating  dyspnoea  requiring  emergency  tracheotomy.  Endoscopic  examination
demonstrated  a tumour  of  the left  hemilarynx  with  ﬁxed  vocal  cords.  Histological  examination  and
immunohistochemistry  demonstrated  lymphoepithelial  carcinoma  of the larynx.  Screening  for  Epstein-
Barr  Virus  (EBV)  by immunohistochemistry  and  in  situ  hybridization  was  positive.  Treatment  consisting  of
neoadjuvant  chemotherapy  followed  by surgical  resection  and  then  external  beam  radiotherapy  achieved
cure  with  a follow-up  of  18  months  since  completion  of treatment.
Discussion: Lymphoepithelial  carcinoma  of  the  larynx  is  rare.  Immunohistochemical  examination  is
essential  for  the  positive  diagnosis.  Epstein-Barr  virus-associated  lymphoepithelial  carcinoma  has  been
exceptionally  reported.  The  radiosensitivity  of  this  tumour  allows  conservative  ﬁrst-line  treatment.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
The most typical form of lymphoepithelial carcinoma is undif-
erentiated nasopharyngeal carcinoma [1,2]. More rarely, this
umour can arise in other sites, especially the salivary glands, thy-
us, lung and stomach [1,3], while laryngeal lymphoepithelial
arcinoma is extremely rare, as only about thirty cases have been
eported in the literature [1]. It represents 0.2% of all malignant
umours of the larynx [1,4,5].
We  report a case of Epstein-Barr virus-associated lymphoep-
thelial carcinoma of the larynx and discuss the pathogenesis,
linical and pathological features and treatment of this tumour.
. Case report
A 73-year-old man, with no notable history, presented with a
-month history of dysphonia with recent onset of rapidly dete-
iorating dyspnoea, requiring emergency tracheotomy. Indirect
aryngoscopy demonstrated a lesion of the left hemilarynx with
xed vocal cords. Neck examination revealed ﬁrm, mobile, deep
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879-7296/© 2015 Elsevier Masson SAS. All rights reserved.cervical lymph nodes measuring 2 cm in diameter. Nasopharyn-
geal endoscopy was normal. CT scan of the neck demonstrated
a left laryngeal tumour extending to the pre-epiglottic space
and left paraglottic space with ipsilateral necrotic jugulo-carotid
lymphadenopathy, with a long axis of 1.8 cm (Fig. 1). Direct
laryngoscopy under general anaesthesia demonstrated a fungat-
ing lesion involving all of the left hemilarynx with inﬁltration of
the pharyngolaryngeal wall. A biopsy was  performed and histolog-
ical examination showed a proliferation composed of moderately
large to large syncytial cells with a vesicular nucleolated nucleus,
basophilic or amphophilic cytoplasm and the presence of numer-
ous mitotic ﬁgures. This tumour was surrounded by a lymphoid
stroma composed of small regular lymphocytes (Fig. 2). Tumour
cells expressed cytokeratin on immunohistochemistry. Screening
for EBV by immunohistochemistry using anti-LMP 1 antibody
(latent membrane protein 1) (Fig. 3A) and in situ hybridization
using the EBER probe (Fig. 3B) was  positive. EBV serology was  in
favour of old EBV infection (negative anti-VCA IgM, positive anti-
VCA IgG, positive anti-EBNA IgG). The diagnosis adopted was  that
of EBV-associated lymphoepithelial carcinoma of the larynx. Stag-
ing assessment (chest X-ray, abdominal ultrasound, bone scan) was
negative. As the tumour was  classiﬁed as T3N1M0, it was decided
to start treatment with neoadjuvant chemotherapy with a combi-
nation of cisplatin and adriamycin. After three cycles, the tumour
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sig. 1. CT scan of the neck, contrast-enhanced axial slice: heterogeneously enhanced
eft laryngeal tumour extending into the left paraglottic space.
esponse, estimated at 30%, was considered to be insufﬁcient. The
ymph node response was 50%. The patient was therefore oper-
ted by total pharyngolaryngectomy with bilateral functional neck
issection. Histological examination of the operative specimen
onﬁrmed left glottic and supraglottic invasion by lymphoepithe-
ial carcinoma with healthy resection margins. Tumour invasion,
ithout capsular rupture, was detected in one of the 18 lymph
odes of the left neck dissection (17 N–, 1 N + R–). None of the 13
odes of the right neck dissection was metastatic (13 N–). External
eam radiotherapy with cobalt 60 was administered postopera-
ively, delivering a dose of 54 Gy to the neck. The patient presented
 favourable outcome with no signs of recurrence with a follow-up
f 18 months since completion of treatment.
. DiscussionLymphoepithelial carcinoma of the larynx usually affects men
etween the ages of 50 and 70 years [1,5]. Clinical symptoms are
ig. 2. Clump of undifferentiated malignant cells with a syncytial appearance ( ),
urrounded by a lymphocyte-rich stroma ( ) (HE × 200).Fig. 3. A. Tumour cells are positive for LMP  1 ( ) (latent membrane protein 1). B. In
situ hybridization: tumour cells express EBV ( ) (HE × 200).
dominated by dysphonia and dysphagia [1,6]. Lymph node invasion
at the time of diagnosis is described in 75% of cases and systemic
metastases are described in 29% of cases [1].
On endoscopic examination, the tumour predominantly
involves the laryngeal ventricle and spreads to the paraglot-
tic and/or pre-epiglottic space [4,5,7] and can therefore have a
misleading appearance with the tumour simply displacing the ven-
tricular band or as ulceration of the epiglottic mucosa [4].
On histological examination, lymphoepithelial carcinoma of the
larynx is composed of clumps or bands of moderately large to
large undifferentiated cells with a syncytial appearance, vesicular
nuclei, often with a high mitotic index. This tumour is surrounded
by non-neoplastic lymphoid stroma, composed of small regular
lymphocytes [3,4]. This histological description corresponds to
type III of the WHO  classiﬁcation of nasopharyngeal carcinoma
[4,8].
The histological diagnosis of lymphoepithelial carcinoma of
the larynx can be difﬁcult on biopsy and even on the operative
specimen, as it raises a problem of differential diagnosis essen-
tially with non-Hodgkin’s lymphoma and malignant melanoma
[1,3]. Immunohistochemistry is able to distinguish these lesions
from lymphoepithelial carcinoma of the larynx by demonstrating
expression of cytokeratin by tumour cells [1,3]. Nasopharyngeal
carcinoma with laryngeal metastasis must also be eliminated.
The pathogenesis of lymphoepithelial carcinoma of the larynx
remains unclear. The role of EBV infection, largely incriminated in
the pathogenesis of nasopharyngeal lymphoepithelial carcinoma, is
much more controversial in the case of lymphoepithelial carcinoma
in other sites [6,8,9].
Only lymphoepithelial carcinomas of the salivary glands, thy-
mus, lung and stomach are regularly associated with EBV [3,6,9].
In lung and salivary gland lymphoepithelial carcinomas, this asso-
ciation with EBV is only observed in South East Asian populations
and Eskimos as in the case of salivary gland tumours [2,3,9]. In
a review of the literature, based on 16 cases of lymphoepithe-
lial carcinoma of the larynx, EBV screening was positive in only
four patients [1]. In our case, screening for EBV by immunohisto-
chemistry and in situ hybridization was strongly positive. To our
knowledge, we  therefore report the ﬁfth case of EBV-associated
lymphoepithelial carcinoma of the larynx. However, the presence
of EBV in lymphoepithelial carcinoma does not appear to have a
major prognostic signiﬁcance [3,5].
In terms of treatment, the radiosensitivity of lymphoepithelial
carcinoma allows conservative ﬁrst-line treatment [1,4,7]. Surgery
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s indicated for locally advanced tumours [4]. Chemotherapy
nsures better distant disease control in patients with lym-
hadenopathy at the time of diagnosis [1,2,5].
. Conclusion
Non-nasopharyngeal lymphoepithelial carcinomas of the head
nd neck are rare epithelial tumours. We  report an exceptional
ase of EBV-associated lymphoepithelial carcinoma of the larynx.
he positive diagnosis must be based on immunohistochem-
stry demonstrating cytokeratin expression to identify the poorly
ifferentiated epithelial component. The role of EBV in the patho-
hysiology of this tumour cannot be clearly determined due to the
mall number of published cases. The radiosensitivity of lymphoep-
thelial carcinoma allows conservative ﬁrst-line treatment.isclosure of interest
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